Home › Type 2 Diabetes › Tennessee
Pag-aaral pangklinika para sa Type 2 Diabetes sa Tennessee
20 pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa mga site sa Tennessee.
Mga Lungsod sa Tennessee
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- West Cancer Center & Research Institute, Germantown
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07748208A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- University Diabetes & Endocrine Consultants, Chattanooga
- LifeDoc Research, PLLC, Memphis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473Gut Microbiota in Metabolic Surgery
- Vanderbilt_University MC, Nashville
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 65 · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT05000996A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Franklin
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07776509A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Vanderbilt Health One Hundred Oaks, Nashville
Nagre-recruitPhase 3
Edad 10 hanggang 17 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07668336A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Kingsport
- Research Site, Nashville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Franklin
- Research Site, Jackson
- Research Site, Knoxville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2026 · NCT07784270A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Memphis
- Research Site, Morristown
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- LifeDoc Health, Memphis
Nagre-recruitPhase 3
Edad 10 hanggang 18 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07282613A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- LifeDoc Health, Memphis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT07668388Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Clinical Research Associates, Nashville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Community DPC, Cleveland
- University of Tennessee Medical Center, Knoxville
- TriStar Centennial Medical Center (HCA Health Care), Nashville
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 55 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06112418A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Memphis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07743450A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- CNS Healthcare, Memphis
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07415954AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Holston Medical Group Pc, Bristol
- The Alliance for Multispecialty Research LLC AMR, Knoxville
- MidState Endocrine Associates, Nashville
Nagre-recruitPhase 3
Edad 45 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Knoxville
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Memphis
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07664553Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- University of Diabetes and Endocrine Consultants, Chattanooga
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07521475Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
- Vanderbilt University Medical Center, Nashville
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT06852950Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.